Literature DB >> 27174453

Thrombocytopenia and fever: not just another infection….

Priya Sriskandarajah1, Rhys Davies2.   

Abstract

Diffuse large B-cell lymphoma (DLBCL) is a high-grade, aggressive disease that typically presents with widespread lymphadenopathy and active 'B' symptoms, making it easy to recognise and manage. However, a small proportion of patients can present with no evidence of lymphadenopathy or organomegaly, with the disease confined to the bone marrow; this presentation is also known as 'Primary Bone Marrow DLBCL'. Subsequently, diagnosis can be a challenge, resulting in delayed treatment and an overall poorer prognosis. Given the rarity of this disease, we wished to describe a patient who presented initially with fevers associated with isolated thrombocytopenia and was later diagnosed with this condition. Unfortunately, due to the aggressive nature of this disease, subsequent treatment was unsuccessful. Overall, we felt that in future cases of fevers with thrombocytopenia, clinicians should include this rare lymphoma subtype as part of the differential diagnosis, as early identification and treatment can be associated with a favourable outcome. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27174453      PMCID: PMC4885347          DOI: 10.1136/bcr-2016-214669

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  Isolated bone marrow non-Hodgkin's lymphoma. Report of two cases and literature review.

Authors:  S Chachashvili; D Almoznino-Sarafian; R Yona; J Sandbank; M Shteinshnaider; D Modai; N Cohen
Journal:  Eur J Intern Med       Date:  2003-03       Impact factor: 4.487

2.  Primary bone marrow B-cell lymphoma: report of four cases.

Authors:  James A Strauchen
Journal:  Mt Sinai J Med       Date:  2003-03

3.  Primary bone marrow diffuse large B cell lymphoma: a case series and review.

Authors:  Hung Chang; Yu-Shin Hung; Tung-Liang Lin; Po-Nan Wang; Ming-Chung Kuo; Tzung-Chih Tang; Jin-Hou Wu; Po Dunn; Lee-Yung Shih
Journal:  Ann Hematol       Date:  2010-12-22       Impact factor: 3.673

4.  Efficacy and safety of rituximab combined with chemotherapy in the treatment of diffuse large B-cell lymphoma: a meta-analysis.

Authors:  Fanlu Meng; Diansheng Zhong; Linlin Zhang; Yi Shao; Qing Ma
Journal:  Int J Clin Exp Med       Date:  2015-10-15

5.  Diffuse large B-cell lymphoma initially manifesting in the bone marrow.

Authors:  Dai Kajiura; Yoriko Yamashita; Naoyoshi Mori
Journal:  Am J Clin Pathol       Date:  2007-05       Impact factor: 2.493

6.  A Case of Primary Bone Marrow B-Cell Non Hodgkin's Lymphoma with Severe Thrombocytopenia: Case Report and A Review of the Literature.

Authors:  Yuki Kagoya; Naohi Sahara; Takashi Matsunaga; Toshimasa Uekusa; Seiji Irie; Kazuhito Hatanaka
Journal:  Indian J Hematol Blood Transfus       Date:  2010-10-06       Impact factor: 0.900

7.  Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms.

Authors:  Constantin Lapa; Markus Knott; Leo Rasche; Ken Herrmann; Andreas K Buck; Andreas Rosenwald
Journal:  Eur J Haematol       Date:  2014-03-26       Impact factor: 2.997

8.  Case Report Diffuse large B-cell lymphoma in the primary bone marrow.

Authors:  Y Hu; S L Chen; Z X Huang; W Gao; N An
Journal:  Genet Mol Res       Date:  2015-06-11

9.  Isolated bone marrow non-Hodgkin's lymphoma: a clinicopathologic study.

Authors:  M Ponzoni; C Y Li
Journal:  Mayo Clin Proc       Date:  1994-01       Impact factor: 7.616

10.  Bone marrow evaluation in initial staging of lymphoma: 18F-FDG PET/CT versus bone marrow biopsy.

Authors:  Montserrat Cortés-Romera; Aida Sabaté-Llobera; Santiago Mercadal-Vilchez; Fina Climent-Esteller; Alfons Serrano-Maestro; Cristina Gámez-Cenzano; Eva González-Barca
Journal:  Clin Nucl Med       Date:  2014-01       Impact factor: 7.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.